3 medicines held by Celgene Europe B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Breyanzi 1.1-70 x 10^6 cells/mL/1.1-70 x 10^6 cells/mL dispersion for infusion EU/1/22/1631/001 |
Lisocabtagene Maraleucel | Celgene Europe B.V. | — |
| Onureg 200 mg film-coated tablets EU/1/21/1556/001-002 |
Azacitidine | Celgene Europe B.V. | — |
| Onureg 300 mg film-coated tablets EU/1/21/1556/003-004 |
Azacitidine | Celgene Europe B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.